Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1952 1
1955 1
1958 1
1962 1
1963 1
1964 3
1965 1
1967 1
1968 2
1969 6
1970 4
1971 4
1972 6
1973 4
1974 4
1975 15
1976 9
1977 11
1978 8
1979 10
1980 8
1981 9
1982 11
1983 22
1984 22
1985 27
1986 14
1987 25
1988 29
1989 20
1990 24
1991 35
1992 37
1993 43
1994 48
1995 44
1996 52
1997 51
1998 68
1999 65
2000 69
2001 89
2002 75
2003 72
2004 110
2005 80
2006 110
2007 119
2008 127
2009 133
2010 180
2011 201
2012 204
2013 220
2014 230
2015 258
2016 241
2017 252
2018 233
2019 253
2020 267
2021 297
2022 311
2023 139

Text availability

Article attribute

Article type

Publication date

Search Results

4,544 results

Results by year

Filters applied: . Clear all
Page 1
Kidney Cancer, Version 3.2022, NCCN Clinical Practice Guidelines in Oncology.
Motzer RJ, Jonasch E, Agarwal N, Alva A, Baine M, Beckermann K, Carlo MI, Choueiri TK, Costello BA, Derweesh IH, Desai A, Ged Y, George S, Gore JL, Haas N, Hancock SL, Kapur P, Kyriakopoulos C, Lam ET, Lara PN, Lau C, Lewis B, Madoff DC, Manley B, Michaelson MD, Mortazavi A, Nandagopal L, Plimack ER, Ponsky L, Ramalingam S, Shuch B, Smith ZL, Sosman J, Dwyer MA, Gurski LA, Motter A. Motzer RJ, et al. Among authors: george s. J Natl Compr Canc Netw. 2022 Jan;20(1):71-90. doi: 10.6004/jnccn.2022.0001. J Natl Compr Canc Netw. 2022. PMID: 34991070 Free PMC article.
NCCN Guidelines® Insights: Uterine Neoplasms, Version 3.2021.
Abu-Rustum NR, Yashar CM, Bradley K, Campos SM, Chino J, Chon HS, Chu C, Cohn D, Crispens MA, Damast S, Diver E, Fisher CM, Frederick P, Gaffney DK, George S, Giuntoli R, Han E, Howitt B, Huh WK, Lea J, Mariani A, Mutch D, Nekhlyudov L, Podoll M, Remmenga SW, Reynolds RK, Salani R, Sisodia R, Soliman P, Tanner E, Ueda S, Urban R, Wethington SL, Wyse E, Zanotti K, McMillian NR, Motter AD. Abu-Rustum NR, et al. Among authors: george s. J Natl Compr Canc Netw. 2021 Aug 1;19(8):888-895. doi: 10.6004/jnccn.2021.0038. J Natl Compr Canc Netw. 2021. PMID: 34416706
Engineering Vascularized Organoid-on-a-Chip Models.
Shirure VS, Hughes CCW, George SC. Shirure VS, et al. Among authors: george sc. Annu Rev Biomed Eng. 2021 Jul 13;23:141-167. doi: 10.1146/annurev-bioeng-090120-094330. Epub 2021 Mar 23. Annu Rev Biomed Eng. 2021. PMID: 33756087 Free article.
Conditional survival and long-term efficacy with nivolumab plus ipilimumab versus sunitinib in patients with advanced renal cell carcinoma.
Motzer RJ, McDermott DF, Escudier B, Burotto M, Choueiri TK, Hammers HJ, Barthélémy P, Plimack ER, Porta C, George S, Powles T, Donskov F, Gurney H, Kollmannsberger CK, Grimm MO, Barrios C, Tomita Y, Castellano D, Grünwald V, Rini BI, McHenry MB, Lee CW, McCarthy J, Ejzykowicz F, Tannir NM. Motzer RJ, et al. Among authors: george s. Cancer. 2022 Jun 1;128(11):2085-2097. doi: 10.1002/cncr.34180. Epub 2022 Apr 5. Cancer. 2022. PMID: 35383908 Free PMC article. Clinical Trial.
Human epigenetic and transcriptional T cell differentiation atlas for identifying functional T cell-specific enhancers.
Giles JR, Manne S, Freilich E, Oldridge DA, Baxter AE, George S, Chen Z, Huang H, Chilukuri L, Carberry M, Giles L, Weng NP, Young RM, June CH, Schuchter LM, Amaravadi RK, Xu X, Karakousis GC, Mitchell TC, Huang AC, Shi J, Wherry EJ. Giles JR, et al. Among authors: george s. Immunity. 2022 Mar 8;55(3):557-574.e7. doi: 10.1016/j.immuni.2022.02.004. Immunity. 2022. PMID: 35263570 Free PMC article.
Rho GTPase signaling in cancer progression and dissemination.
Crosas-Molist E, Samain R, Kohlhammer L, Orgaz JL, George SL, Maiques O, Barcelo J, Sanz-Moreno V. Crosas-Molist E, et al. Among authors: george sl. Physiol Rev. 2022 Jan 1;102(1):455-510. doi: 10.1152/physrev.00045.2020. Epub 2021 Sep 20. Physiol Rev. 2022. PMID: 34541899 Free article. Review.
Regorafenib for the Treatment of Sarcoma.
Blay JY, Duffaud F, George S, Maki RG, Penel N. Blay JY, et al. Among authors: george s. Curr Treat Options Oncol. 2022 Nov;23(11):1477-1502. doi: 10.1007/s11864-022-00990-0. Epub 2022 Sep 30. Curr Treat Options Oncol. 2022. PMID: 36178573 Review.
4,544 results